A shadow market for unapproved slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and assertions of next-day British shipping. Sellers market the drug there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users injecting products of unknown origin.
Several experts said the popularity for retatrutide could be connected to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Content Elimination
Based on TikTok, the service has taken down problematic content and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
After moments of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or past usage.
Product Information and Pricing
Inside these communities, posts show black plastic packages with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When asked how long a pen should last, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her team has already encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to potentially serious health risks”.
